| Document Date: 2011-10-24 17:06:29
Open Document File Size: 181,31 KBShare Result on Facebook
Company Soerens AG / iPSCs / reported generating iPSCs / / Event Product Issues / / Facility Kyoto University / / IndustryTerm Live cell imaging / potential applications / potentIal medICal applICatIons / clinical tool / countless prospective applications / putative regenerative medicine applications / clinical tools / multi-purpose tools / iPSC technology / proposed autologous therapy applications / iPSC-generation protocols / chemical inhibitors / chemicals / / MedicalCondition tumor / Alzheimer’s disease / Lou Gehrig’s disease / model diseases / spinal muscular atrophy / tumors / disease / dysfunction / ALS / patient’s disease / Huntington’s disease / cardiovascular disease / diabetes / amyotrophic lateral sclerosis / Gaucher disease / diabetes mellitus / Parkinson’s disease / diseases / muscular dystrophies / degenerative disease / specific genetically-inherited disease / successfully modeling disease / ShwachmanBodian-Diamond syndrome / Down syndrome / / MedicalTreatment cell therapy / / Organization Kyoto University in Japan / Melton DA / / Person Terese Winslow Somatic / Charles A. Goldthwaite / Lou Gehrig / / Position Hurlbut WB / / Product iRiver E30 Portable Audio Device / adenosine / maturation / / PublishedMedium PLoS One / / Technology iPSC-generation protocols / cell therapy / nuclear transfer / gene expression / Reprogramming technology / Cloning / transplantation / stem Cells / drug development / regenerative medicine / iPSC technology / /
SocialTag |
The Promise of Induced Pluripotent Stem Cells (iPSCs)